Travere Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Travere Therapeutics

01/11/2024 03:50

* Travere Therapeutics Inc  TVTX.OQ  reported a quarterly
adjusted
loss of 70 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-1.17.  The mean expectation of
fifteen analysts for the quarter was for a loss of 68 cents per
share. Wall Street expected results to range from -97 cents
to -50 cents per share.
    * Revenue fell 94.9% to $1.90 million from a year ago;
analysts
expected $60.48 million. 
    * Travere Therapeutics Inc's reported EPS for the quarter
was a
loss of 70 cents​.
    * The company reported a quarterly loss of $54.81 million.
    * Travere Therapeutics Inc shares had risen by 26.9% this
quarter and gained 97.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Travere
Therapeutics Inc is $24.50 
This summary was machine generated from LSEG data November 1 at
03:50 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.68          -0.70          Missed
 Jun. 30 2024      -0.86          -0.91          Missed
 Mar. 31 2024      -0.99          -1.76          Missed
 Dec. 31 2023      -1.27          -1.03          Beat